Sofinnova Investments, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Sofinnova Investments, Inc.

  • $1.06 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$336.18 - $494.43 $16.8 Million - $24.8 Million
-50,086 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $13.7 Million - $18.9 Million
50,086 New
50,086 $18.8 Million
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $371,118 - $449,866
-1,304 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $411,829 - $513,489
1,304 New
1,304 $449,000

Others Institutions Holding REGN

# of Institutions
1,535
Shares Held
83.8M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email